Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta

被引:30
作者
Boyd, Justin D.
Jang, Haeman
Shepherd, Kennie R.
Faherty, Ciaran
Slack, Sally
Jiao, Yun
Smeyne, Richard J.
机构
[1] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA
[2] Univ Tennessee, Ctr Hlth Sci, Integrated Programs Biomed Sci, Memphis, TN 38163 USA
关键词
Parkinson's disease; oxidative stress; dopamine transporter; VMAT2; signal transduction; neuroinflammation; COX-2;
D O I
10.1016/j.brainres.2007.07.067
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disease whose hallmark pathological features include a selective loss of dopaminergic neurons in the midbrain. Recent studies have described the activation of a stress-induced signal cascade, c-Jun N-terminal kinase (JNK)-mediated activation of c-Jun, and an increase in the expression of a downstream effector, cyclooxygenase 2 (COX-2), in postmortem PD brains. The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which induces selective neuronal loss in the midbrain similar to that seen in PD, also induces JNK-mediated activation of c-Jun and generates a COX-2 response in C57BL/6J mice. However, mice exhibit a strain-dependent susceptibility to MPTP. Identifying the point(s) of molecular divergence in the MPTP-induced response may provide insight into the cause of PD or a means to identify susceptibility to PD in humans. Here we examined JNK signaling and COX-2 induction in two strains of mice, the MPTP-sensitive C57BL/6J and the MPTP-resistant Swiss Webster (SW). We show that C57BL/6J and SW strains differ in JNK and c-Jun activation in response to MPTP. In addition, the MPTP-induced COX-2 response occurs exclusively in C57BL/6J mice. Furthermore, strain-specific responses to MPTP are not due to differences in MPP+ levels and are not secondary to cell death. These results provide evidence toward a mechanism of strain-dependent sensitivity to MPTP. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 49 条
[41]  
Staal RGW, 2000, J PHARMACOL EXP THER, V293, P329
[42]  
SUNDSTROM E, 1987, BRAIN RES, V405, P26
[43]   Epidemiology of Parkinson's disease [J].
Tanner, CM ;
Goldman, SM .
NEUROLOGIC CLINICS, 1996, 14 (02) :317-+
[44]  
Teismann P, 2003, ANN NY ACAD SCI, V991, P272
[45]   Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration [J].
Teismann, P ;
Tieu, K ;
Choi, DK ;
Wu, DC ;
Naini, A ;
Hunot, S ;
Vila, M ;
Jackson-Lewis, V ;
Przedborski, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) :5473-5478
[46]   Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus [J].
Wang, T ;
Arifoglu, P ;
Ronai, Z ;
Tew, KD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :20999-21003
[47]   SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease [J].
Wang, WY ;
Shi, LY ;
Xie, YB ;
Ma, C ;
Li, WM ;
Su, XW ;
Huang, SJ ;
Chen, RH ;
Zhu, ZY ;
Mao, ZX ;
Han, YF ;
Li, MT .
NEUROSCIENCE RESEARCH, 2004, 48 (02) :195-202
[48]   Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease [J].
Xia, XG ;
Harding, T ;
Weller, M ;
Bieneman, A ;
Uney, JB ;
Schulz, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10433-10438
[49]  
Yin ZM, 2000, CANCER RES, V60, P4053